1. Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer: Single-center Preliminary Results. (December 2020) Authors: Zolcsák, Zita; Loirat, Delphine; Fourquet, Alain; Kirova, Youlia M. Journal: American journal of clinical oncology Issue: Volume 43:Number 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗